EA032920B1 - Способы получения соединений бензохинолина - Google Patents
Способы получения соединений бензохинолинаInfo
- Publication number
- EA032920B1 EA032920B1 EA201691162A EA201691162A EA032920B1 EA 032920 B1 EA032920 B1 EA 032920B1 EA 201691162 A EA201691162 A EA 201691162A EA 201691162 A EA201691162 A EA 201691162A EA 032920 B1 EA032920 B1 EA 032920B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- manufacturing
- benzoquinoline compounds
- manufacturing benzoquinoline
- compounds
- Prior art date
Links
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical class C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 102000009659 Vesicular Monoamine Transport Proteins Human genes 0.000 abstract 2
- 108010020033 Vesicular Monoamine Transport Proteins Proteins 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
- C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
- C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361911214P | 2013-12-03 | 2013-12-03 | |
| PCT/US2014/067117 WO2015084622A1 (en) | 2013-12-03 | 2014-11-24 | Methods of manufacturing benzoquinoline compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201691162A1 EA201691162A1 (ru) | 2016-11-30 |
| EA032920B1 true EA032920B1 (ru) | 2019-08-30 |
Family
ID=53264424
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201691162A EA032920B1 (ru) | 2013-12-03 | 2014-11-24 | Способы получения соединений бензохинолина |
| EA201791466A EA201791466A1 (ru) | 2013-12-03 | 2014-11-24 | Способы получения соединений бензохинолина |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201791466A EA201791466A1 (ru) | 2013-12-03 | 2014-11-24 | Способы получения соединений бензохинолина |
Country Status (14)
| Country | Link |
|---|---|
| US (8) | US20150152099A1 (enExample) |
| EP (2) | EP3076970A4 (enExample) |
| JP (1) | JP6542222B2 (enExample) |
| KR (1) | KR102391134B1 (enExample) |
| CN (1) | CN105873589B (enExample) |
| AU (4) | AU2014357518A1 (enExample) |
| BR (1) | BR112016012747B1 (enExample) |
| CA (1) | CA2930744A1 (enExample) |
| EA (2) | EA032920B1 (enExample) |
| HK (1) | HK1224222A1 (enExample) |
| IL (1) | IL245539B (enExample) |
| MX (1) | MX369956B (enExample) |
| NZ (1) | NZ720301A (enExample) |
| WO (1) | WO2015084622A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9550780B2 (en) | 2012-09-18 | 2017-01-24 | Auspex Pharmaceuticals, Inc. | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| CA2883641C (en) | 2012-09-18 | 2021-09-14 | Auspex Pharmaceuticals, Inc. | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| CN105873589B (zh) | 2013-12-03 | 2019-11-01 | 奥斯拜客斯制药有限公司 | 制造苯并喹啉化合物的方法 |
| CN114767672A (zh) | 2015-03-06 | 2022-07-22 | 奥斯拜客斯制药有限公司 | 氘代丁苯那嗪或包含氘代丁苯那嗪的组合物 |
| US10479787B2 (en) * | 2016-04-22 | 2019-11-19 | Lupin Limited | Process for preparation of tetrabenazine and deutetrabenazine |
| WO2018130345A1 (en) | 2017-01-10 | 2018-07-19 | Sandoz Ag | Crystalline valbenazine free base |
| CA3054238A1 (en) | 2017-02-27 | 2018-08-30 | Sandoz Ag | Crystalline forms of valbenazine salts |
| US11813232B2 (en) | 2017-03-15 | 2023-11-14 | Auspex Pharmaceuticals, Inc. | Analogs of deutetrabenazine, their preparation and use |
| WO2019130252A2 (en) * | 2017-12-29 | 2019-07-04 | Mylan Laboratories Ltd | Methods and intermediates for preparing deutetrabenazine |
| US11505549B2 (en) * | 2018-02-01 | 2022-11-22 | Lakshmi Prasad ALAPARTHI | Process for preparation of Deutetrabenazine |
| JP7603199B2 (ja) | 2018-10-18 | 2024-12-20 | オンコペプティデス・イノベーション・エービー | 重水素を含有する化合物 |
| WO2020086765A1 (en) * | 2018-10-24 | 2020-04-30 | Neurocrine Biosciences, Inc. | Processes for preparing a vmat2 inhibitor |
| CN111960999B (zh) * | 2020-07-20 | 2021-11-02 | 暨明医药科技（苏州）有限公司 | 一种丁苯那嗪中间体的合成方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080167337A1 (en) * | 2006-11-08 | 2008-07-10 | Gano Kyle W | Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto |
| WO2012081031A1 (en) * | 2010-12-15 | 2012-06-21 | Enaltec Labs Pvt. Ltd. | Process for preparing tetrabenazine |
| CN102936246A (zh) * | 2012-11-08 | 2013-02-20 | 江苏暨明医药科技有限公司 | 丁苯那嗪的合成方法 |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2843591A (en) | 1958-07-15 | Method for preparing same | ||
| US2830993A (en) | 1958-04-15 | Quinolizine derivatives | ||
| US2326643A (en) | 1941-08-20 | 1943-08-10 | Rohm & Haas | Complex polyamino sulphur compound |
| US3045021A (en) | 1959-09-24 | 1962-07-17 | Hoffmann La Roche | Preparation of substituted 2-oxobenzoquinolizines |
| GB999095A (en) * | 1961-02-21 | 1965-07-21 | Wellcome Found | The preparation of quinolizine derivatives |
| HU175890B (en) | 1977-06-15 | 1980-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new 1,2,3,4,6,7-hexahydro-11-b-alpha-benzo-square bracket-a-square brecket closed-quinolyzine derivatives |
| US4316897A (en) | 1980-09-10 | 1982-02-23 | Hoffmann-La Roche Inc. | Method of lowering serum prolactin |
| DE3407955A1 (de) | 1984-03-03 | 1985-09-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Arzneimittel, enthaltend quartaere 3,4-dihydroisochinoliniumsalze |
| US5451409A (en) | 1993-11-22 | 1995-09-19 | Rencher; William F. | Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends |
| US6221335B1 (en) | 1994-03-25 | 2001-04-24 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| CN1087725C (zh) | 1994-03-25 | 2002-07-17 | 同位素技术有限公司 | 用氘代方法增强药物效果 |
| GB9817028D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Plc | Novel compounds |
| US6440710B1 (en) | 1998-12-10 | 2002-08-27 | The Scripps Research Institute | Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds |
| DK1104760T3 (da) | 1999-12-03 | 2003-06-30 | Pfizer Prod Inc | Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler |
| EP1134290A3 (en) | 2000-03-14 | 2004-01-02 | Pfizer Products Inc. | Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors |
| US6488962B1 (en) | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
| US6287599B1 (en) | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
| CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| TW200413273A (en) | 2002-11-15 | 2004-08-01 | Wako Pure Chem Ind Ltd | Heavy hydrogenation method of heterocyclic rings |
| CA2673334C (en) | 2003-06-16 | 2013-11-12 | Andrx Pharmaceuticals, Llc | Oral extended-release composition |
| ES2309594T3 (es) | 2003-11-21 | 2008-12-16 | Memory Pharmaceuticals Corporation | Composiciones que contienen bloqueadores de los canales de calcio de tipo l e inhibidores de la colinesterasa. |
| US7367953B2 (en) | 2003-11-26 | 2008-05-06 | Ge Medical Systems Global Technology Company | Method and system for determining a period of interest using multiple inputs |
| GB2410947B (en) | 2004-02-11 | 2008-09-17 | Cambridge Lab Ltd | Pharmaceutical compounds |
| WO2006053067A2 (en) | 2004-11-09 | 2006-05-18 | Prestwick Pharmaceuticals, Inc. | Combination of amantadine and a tetrabenazine compound for treating hyperkinetic disorders |
| JP4801096B2 (ja) | 2005-01-19 | 2011-10-26 | ライジェル ファーマシューティカルズ， インコーポレイテッド | ２，４−ピリミジンジアミン化合物のプロドラッグおよびそれらの使用 |
| AU2006261893A1 (en) | 2005-06-23 | 2007-01-04 | Combinatorx, Incorporated | Improved dosage forms for movement disorder treatment |
| US20080033011A1 (en) | 2005-07-29 | 2008-02-07 | Concert Pharmaceuticals Inc. | Novel benzo[d][1,3]-dioxol derivatives |
| US7750168B2 (en) | 2006-02-10 | 2010-07-06 | Sigma-Aldrich Co. | Stabilized deuteroborane-tetrahydrofuran complex |
| BRPI0708071A8 (pt) | 2006-02-17 | 2017-12-26 | Birds Pharma Gmbh Berolina Innovative Res & Development Services | Derivados de catecolamina deuterada e medicamentos compreendendo os ditos compostos |
| BRPI0711481A8 (pt) | 2006-05-02 | 2017-11-28 | Univ Michigan Regents | derivados radiomarcados de dihidrotetrabenzeno e seu uso como agente de imagens |
| HU227610B1 (en) | 2006-09-18 | 2011-09-28 | Richter Gedeon Nyrt | Pharmaceutical compositions containing rosuvastatin potassium |
| BRPI0719189A2 (pt) | 2006-10-12 | 2018-08-14 | Univ Kyushu Nat Univ Corp | uso de ciclosporinas modificadas |
| ES2380551T3 (es) | 2006-11-21 | 2012-05-16 | Rigel Pharmaceuticals, Inc. | Sales de profármaco de compuestos de 2,4-pirimidindiamina y sus usos |
| WO2008112278A2 (en) | 2007-03-12 | 2008-09-18 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for modulating insulin secretion and glucose metabolism |
| US8008500B2 (en) | 2007-06-08 | 2011-08-30 | General Electric Company | Intermediates useful for making tetrabenazine compounds |
| DK2173344T3 (en) | 2007-06-29 | 2016-07-25 | Clarencew Pty Ltd | TREATMENT OR PROPHYLAXIS OF NEUROLOGICAL OR NEURO PSYCHIATRIC DISORDERS USING ocular administration |
| US8053578B2 (en) | 2007-11-29 | 2011-11-08 | General Electric Company | Alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes |
| US7902364B2 (en) | 2007-11-29 | 2011-03-08 | General Electric Company | Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| WO2009124357A1 (en) | 2008-04-10 | 2009-10-15 | Malvin Leonard Eutick | Fast dissolving oral formulations for critical drugs |
| US9012471B2 (en) | 2008-04-11 | 2015-04-21 | The Trustees Of Columbia University In The City Of New York | Glucose metabolism modulating compounds |
| CN201204923Y (zh) | 2008-04-14 | 2009-03-11 | 云南省烟草公司昆明市公司 | 鲜烟叶编叶机 |
| ES2732453T3 (es) | 2008-07-01 | 2019-11-22 | Curemark Llc | Métodos y composiciones para el tratamiento de síntomas de trastornos neurológicos y de salud mental |
| DE102008040212A1 (de) | 2008-07-07 | 2010-01-14 | Zf Friedrichshafen Ag | Radaufhängung für ein Fahrzeug |
| GB2462611A (en) | 2008-08-12 | 2010-02-17 | Cambridge Lab | Pharmaceutical composition comprising tetrabenazine |
| US20110053866A1 (en) | 2008-08-12 | 2011-03-03 | Biovail Laboratories International (Barbados) S.R.L. | Pharmaceutical compositions |
| CA2736409C (en) | 2008-09-18 | 2017-07-11 | Auspex Pharmaceutical, Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| US20100113496A1 (en) | 2008-09-25 | 2010-05-06 | Auspex Pharmaceuticals, Inc. | Piperidine modulators of vmat2 |
| US20120053159A1 (en) | 2009-02-11 | 2012-03-01 | Muller George W | Isotopologues of lenalidomide |
| JP2013501810A (ja) | 2009-08-12 | 2013-01-17 | ヴァリーント インターナショナル（バルバドス）エスアールエル | 医薬組成物 |
| JP4679658B2 (ja) | 2009-10-10 | 2011-04-27 | 株式会社オーバル | フィールド機器の光電センシング感度調整 |
| CN102120742B (zh) | 2010-01-08 | 2013-03-13 | 中国药科大学 | 一种丁苯那嗪的制备方法 |
| US20110206782A1 (en) | 2010-02-24 | 2011-08-25 | Auspex Pharmaceuticals, Inc. | Piperidine modulators of dopamine receptor |
| CA2790199A1 (en) | 2010-02-24 | 2011-09-01 | Auspex Pharmaceuticals, Inc. | Trimethoxyphenyl inhibitors of tyrosine kinase |
| CA2801061A1 (en) * | 2010-06-01 | 2011-12-08 | Auspex Pharmaceuticals, Inc. | Benzoquinolone inhibitors of vmat2 |
| WO2012006551A2 (en) | 2010-07-08 | 2012-01-12 | The Brigham And Women's Hospital, Inc. | Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules |
| WO2012079022A1 (en) | 2010-12-10 | 2012-06-14 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
| CN102260255B (zh) | 2011-07-07 | 2013-07-10 | 江苏省原子医学研究所 | 一种9,10-二甲氧基-1,3,4,6,7,11b-六氢-3-异丁基-2H-苯并[a]喹嗪-2-酮的简便合成方法 |
| WO2013061161A2 (en) | 2011-10-28 | 2013-05-02 | Green Bcn Consulting Services Sl | New combination therapies for treating neurological disorders |
| KR101362482B1 (ko) | 2012-01-31 | 2014-02-12 | 한국과학기술연구원 | 테트라베나진과 다이하이드로테트라베나진의 제조방법 |
| US9901564B2 (en) | 2012-03-23 | 2018-02-27 | Cardero Therapeutics, Inc. | Compounds and compositions for the treatment of muscular disorders |
| CA2883641C (en) | 2012-09-18 | 2021-09-14 | Auspex Pharmaceuticals, Inc. | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| WO2014120654A1 (en) | 2013-01-31 | 2014-08-07 | Auspex Pharmaceuticals, Inc. | Benzoquinolone inhibitors of vmat2 |
| HK1221645A1 (zh) | 2013-09-27 | 2017-06-09 | Auspex Pharmaceuticals, Inc. | Vmat2的苯并喹啉抑制剂 |
| WO2015077521A1 (en) | 2013-11-22 | 2015-05-28 | Auspex Pharmaceuticals, Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| WO2015077520A1 (en) | 2013-11-22 | 2015-05-28 | Auspex Pharmaceuticals, Inc. | Methods of treating abnormal muscular activity |
| CN105873589B (zh) | 2013-12-03 | 2019-11-01 | 奥斯拜客斯制药有限公司 | 制造苯并喹啉化合物的方法 |
| CA2936823A1 (en) | 2014-01-27 | 2015-07-30 | Auspex Pharmaceuticals, Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
-
2014
- 2014-11-24 CN CN201480066154.9A patent/CN105873589B/zh active Active
- 2014-11-24 AU AU2014357518A patent/AU2014357518A1/en not_active Abandoned
- 2014-11-24 HK HK16112664.2A patent/HK1224222A1/zh unknown
- 2014-11-24 JP JP2016536571A patent/JP6542222B2/ja active Active
- 2014-11-24 CA CA2930744A patent/CA2930744A1/en not_active Abandoned
- 2014-11-24 US US14/551,909 patent/US20150152099A1/en not_active Abandoned
- 2014-11-24 KR KR1020167017402A patent/KR102391134B1/ko active Active
- 2014-11-24 NZ NZ720301A patent/NZ720301A/en unknown
- 2014-11-24 EP EP14867514.3A patent/EP3076970A4/en not_active Withdrawn
- 2014-11-24 MX MX2016007056A patent/MX369956B/es active IP Right Grant
- 2014-11-24 BR BR112016012747-1A patent/BR112016012747B1/pt active IP Right Grant
- 2014-11-24 EA EA201691162A patent/EA032920B1/ru not_active IP Right Cessation
- 2014-11-24 EP EP18179389.4A patent/EP3424504A1/en not_active Withdrawn
- 2014-11-24 WO PCT/US2014/067117 patent/WO2015084622A1/en not_active Ceased
- 2014-11-24 EA EA201791466A patent/EA201791466A1/ru unknown
-
2016
- 2016-05-08 IL IL245539A patent/IL245539B/en active IP Right Grant
-
2017
- 2017-03-21 US US15/464,938 patent/US20170190654A1/en not_active Abandoned
- 2017-03-29 US US15/472,779 patent/US10513488B2/en active Active
-
2018
- 2018-04-12 US US15/952,031 patent/US20180230083A1/en not_active Abandoned
- 2018-11-30 US US16/205,525 patent/US20190092719A1/en not_active Abandoned
-
2019
- 2019-11-12 US US16/680,674 patent/US20200331846A1/en not_active Abandoned
-
2020
- 2020-02-14 AU AU2020201091A patent/AU2020201091B2/en active Active
- 2020-04-15 US US16/849,603 patent/US20200347008A1/en not_active Abandoned
-
2021
- 2021-07-26 AU AU2021209150A patent/AU2021209150A1/en not_active Abandoned
-
2022
- 2022-08-02 US US17/879,600 patent/US12077487B2/en active Active
-
2023
- 2023-05-23 AU AU2023203246A patent/AU2023203246B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080167337A1 (en) * | 2006-11-08 | 2008-07-10 | Gano Kyle W | Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto |
| WO2012081031A1 (en) * | 2010-12-15 | 2012-06-21 | Enaltec Labs Pvt. Ltd. | Process for preparing tetrabenazine |
| CN102936246A (zh) * | 2012-11-08 | 2013-02-20 | 江苏暨明医药科技有限公司 | 丁苯那嗪的合成方法 |
Non-Patent Citations (2)
| Title |
|---|
| PUBCHEM. Compound Summary for 54765059. Create Date: 2012-01-16 [retrieved on 31 December 2014]. Retrieved from the Internet <URL: https://pubchem.ncbi.nlm.nih.gov/compound/54765059> entire document * |
| PUBCHEM. Compound Summary for AGN-PC-01VNZU. Create Date: 2007-12-04 [retrieved on 31 December 2014]. Retrieved from the Internet <URL: https://pubchem.ncbi.nlm.nih.gov/compound/18412075> entire document * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1224222A1 (zh) | 制造苯并喹啉化合物的方法 | |
| MX2021003792A (es) | Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2. | |
| JOP20200225A1 (ar) | مشتق كوينولين عالي النقاء وطريقة لإنتاجه | |
| MX2016003843A (es) | Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos. | |
| MX2020001756A (es) | Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos. | |
| CY1119105T1 (el) | Παραγωγα διπυραζολιου ως αναστολεις jak | |
| SG10201809518QA (en) | Processes of preparing a jak1 inhibitor and new forms thereto | |
| MX2015008999A (es) | Inhibidores mk2 y usos de los mismos. | |
| EA201891211A1 (ru) | Ингибиторы cxcr2 | |
| MX2015017156A (es) | Inhibidores de bace. | |
| PH12016500347A1 (en) | Triazolopyridine compounds, compositions and methods of use thereof | |
| EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
| TW201613934A (en) | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | |
| IN2013MU00848A (enExample) | ||
| NZ742952A (en) | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | |
| EA201790982A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
| HK1221645A1 (zh) | Vmat2的苯并喹啉抑制剂 | |
| MX2015013589A (es) | Proceso e intermediario para la preparacion de pregabalina. | |
| CY1121116T1 (el) | Νεα μεθοδος για την συνθεση αγομελατινης | |
| MX379401B (es) | Carboxamidas de quinolina para usarse en el tratamiento de leucemia. | |
| MX2017010567A (es) | Dimetoxifenilos como inhibidores del transportador de monoamina vesicular 2. | |
| EA201690749A1 (ru) | Новые ингибиторы sglt1 | |
| CY1121313T1 (el) | Φαρμακευτικη διεργασια και ενδιαμεσα | |
| MX2016005511A (es) | Intermediarios y metodos para sintetizar derivados de calicheamicina. | |
| MX2016005220A (es) | Tinturas acidas, proceso para su produccion y su uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KG TJ TM |